News

GLP-1 weight loss medications like Ozempic and Wegovy could increase testosterone levels and help prevent erectile ...
Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...
Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...
GLP-1 drugs like Ozempic and Mounjaro helped men with low testosterone raise their levels without hormone replacement in a ...
On its clinic website, the supermarket chain said the self-injectable pens can be used once a week to increase a user’s chance of sustained weight loss, amounted to around 20% of their bodyweight in a ...
Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...
Recent research suggests that men who work with pesticides are at a higher risk for erectile dysfunction (ED) (Glover et al., 2024; Yang et al., 2022). Why are we largely ignore this reality?
Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being ...
The largest DTI-ALPS study to date, which included 2,219 participants, found that GS dysfunction, as reflected by DTI-ALPS, is closely related to the occurrence and severity of CSVD. Moreover, the ...
Assessment of sexual dysfunction among adult male survivors of childhood cancer has primarily been limited to erectile dysfunction. This study aimed to characterize sexual functioning more ...
A new study reveals that rectal spacers during prostate cancer radiation therapy significantly reduce long-term erectile dysfunction rates, enhancing patient outcomes.